Patents Assigned to Dana-Farber Cancer, Inc.
  • Chelerythrine-based therapies for cancer
    Patent number: 6426351
    Abstract: Chelerythrine is an effective inhibitor of solid tumor growth and is extremely cytotoxic in combination with chemotherapeutic agents that directly damage DNA.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: July 30, 2002
    Assignees: Dana-Farber Cancer, Inc., Arch Development Corporation
    Inventors: Ralph R. Weichselbaum, Donald W. Kufe, Steven J. Chmura, Mary E. Dolan